Dimensional Fund Advisors LP Viracta Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.89 - $2.13 $63,673 - $152,386	-71,543 Reduced 57.5%	52,888 $74,000
Q1 2023 May 12, 2023	SELL	$1.38 - $2.29 $76,162 - $126,385	-55,190 Reduced 30.73%	124,431 $197,000
Q4 2022 Feb 09, 2023	BUY	$1.26 - $4.38 $41,945 - $145,810	33,290 Added 22.75%	179,621 $262,000
Q3 2022 Nov 10, 2022	BUY	$3.32 - $5.69 $485,818 - $832,623	146,331 New	146,331 $625,000

5.63M

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $9.39M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.